title: Short-course therapy for recurrent genital herpes and herpes labialis.
authors.affiliation: Division of Infectious Diseases, University of Utah School of Medicine, Room 4B319, 30 North 1900 East, Salt Lake City, UT 84132-2405, USA. woody.spruance@hsc.utah.edu
authors.forename: Spotswood
authors.initials: S
authors.lastname: Spruance
authors.forename: Fred Y
authors.initials: FY
authors.lastname: Aoki
authors.forename: Stephen
authors.initials: S
authors.lastname: Tyring
authors.forename: Lawrence
authors.initials: L
authors.lastname: Stanberry
authors.forename: Richard
authors.initials: R
authors.lastname: Whitley
authors.forename: Kamal
authors.initials: K
authors.lastname: Hamed
mesh_terms: D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D042241:Early Diagnosis; D019317:Evidence-Based Medicine; D005194:Family Practice; D005260:Female; D005500:Follow-Up Studies; D006558:Herpes Genitalis / Q000175:diagnosis* / Q000188:drug therapy*; D006560:Herpes Labialis / Q000175:diagnosis* / Q000188:drug therapy*; D018259:Herpesvirus 1, Human / Q000187:drug effects / Q000302:isolation & purification; D018258:Herpesvirus 2, Human / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D008297:Male; D018570:Risk Assessment; D055502:Secondary Prevention; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D000212:Acyclovir